274 related articles for article (PubMed ID: 35756304)
1. Sadder but Wiser: The Role of SARS Imprinting and Firms' Recovery During the COVID-19 Pandemic.
Yao H; Wang J; Bo Q; Li M
Front Psychol; 2022; 13():917337. PubMed ID: 35756304
[TBL] [Abstract][Full Text] [Related]
2. Understanding cognitive differences in the effect of digitalization on ambidextrous innovation: Moderating role of industrial knowledge base.
Xu Q; Liu H; Chen Y; Tian K
Front Psychol; 2022; 13():983844. PubMed ID: 36176792
[TBL] [Abstract][Full Text] [Related]
3. Financing Constraints and Firm's Productivity Under the COVID-19 Epidemic Shock: Evidence of A-Shared Chinese Companies.
Wong Z; Chen A; Taghizadeh-Hesary F; Li R; Kong Q
Eur J Dev Res; 2023; 35(1):167-195. PubMed ID: 35194343
[TBL] [Abstract][Full Text] [Related]
4. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
He Z; Suardi S; Wang K; Zhao Y
Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
[TBL] [Abstract][Full Text] [Related]
5. The influence of firm's feedbacks on user-generated content's linguistic style matching-An explanation based on communication accommodation theory.
Liu D; Gong C; Zhang S; Ma Y
Front Psychol; 2022; 13():949968. PubMed ID: 35936319
[TBL] [Abstract][Full Text] [Related]
6. Reacting to the economic fallout of the COVID-19: Evidence on debt exposure and asset management of Italian firms.
Ferragina AM; Iandolo S
Econ Anal Policy; 2022 Sep; 75():530-547. PubMed ID: 35754528
[TBL] [Abstract][Full Text] [Related]
7. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
Zheng F; Zhao Z; Sun Y; Khan YA
Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
[TBL] [Abstract][Full Text] [Related]
8. How R&D intensive firms react to the COVID-19 pandemic: Evidence from a quasi-natural experiment.
Pham THL; Nguyen DHT; Chu VT; Nguyen KD; Pham BT
Heliyon; 2023 Sep; 9(9):e19329. PubMed ID: 37662736
[TBL] [Abstract][Full Text] [Related]
9. Impact of the COVID-19 pandemic: Evidence from the U.S. restaurant industry.
Song HJ; Yeon J; Lee S
Int J Hosp Manag; 2021 Jan; 92():102702. PubMed ID: 33024347
[TBL] [Abstract][Full Text] [Related]
10. 'Guidance' or 'Misleading'? The government subsidy and the choice of enterprise innovation strategy.
Ding J; Wang J; Liu B; Peng L
Front Psychol; 2022; 13():1005563. PubMed ID: 36267081
[TBL] [Abstract][Full Text] [Related]
11. How does social responsibility investment strategy contribute to hospitality firms' recovery from public health emergencies? The case of COVID-19 pandemic.
Wu D; Li H; Yang J
Int J Hosp Manag; 2023 Aug; 113():103530. PubMed ID: 37292494
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
Akram A; Tang Y; Tariq J
Front Psychol; 2020; 11():1624. PubMed ID: 32903572
[TBL] [Abstract][Full Text] [Related]
13. The impact of corporate digital transformation on firms' performance in utilities sector.
Wang D; Xia X
Heliyon; 2024 Jan; 10(1):e23362. PubMed ID: 38169836
[TBL] [Abstract][Full Text] [Related]
14. Firms' solidity before an exogenous shock: Covid-19 pandemic in Italy.
Costa S; Sallusti F; Vicarelli C; Zurlo D
Econ Anal Policy; 2022 Dec; 76():946-961. PubMed ID: 36277035
[TBL] [Abstract][Full Text] [Related]
15. Crisis Preparedness of Healthcare Manufacturing Firms during the COVID-19 Outbreak: Digitalization and Servitization.
Zhang J; Qi L
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065212
[TBL] [Abstract][Full Text] [Related]
16. Does the CEOs' hometown identity matter for firms' environmental, social, and governance (ESG) performance?
Wang L; Zhang Y; Qi C
Environ Sci Pollut Res Int; 2023 Jun; 30(26):69054-69063. PubMed ID: 37127738
[TBL] [Abstract][Full Text] [Related]
17. Investing for keeps: Firms' prepandemic investments in human capital decreased workforce reductions associated with COVID-19 financial pressures.
Bentley FS; Kehoe RR; Chung H
J Appl Psychol; 2021 Dec; 106(12):1785-1804. PubMed ID: 34968090
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
Sun Y; Li Y
Front Public Health; 2021; 9():710743. PubMed ID: 34604155
[TBL] [Abstract][Full Text] [Related]
19. Firms' responses to the COVID-19 pandemic.
Klöckner M; Schmidt CG; Wagner SM; Swink M
J Bus Res; 2023 Mar; 158():113664. PubMed ID: 36685011
[TBL] [Abstract][Full Text] [Related]
20. Does CSR Activity Amount to Socially Responsible Management?
Foster MJ
Philos Manag; 2021; 20(4):391-410. PubMed ID: 33526999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
